Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
21.7M
-
Shares change
-
-5.75M
-
Total reported value, excl. options
-
$101M
-
Value change
-
-$33.4M
-
Put/Call ratio
-
6.87
-
Number of buys
-
54
-
Number of sells
-
-19
-
Price
-
$4.65
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q4 2016
94 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q4 2016.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.7M shares
of 159M outstanding shares and own 13.66% of the company stock.
Largest 10 shareholders include BRIDGER MANAGEMENT, LLC (4.92M shares), FMR LLC (3.79M shares), VANGUARD GROUP INC (1.54M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.54M shares), BlackRock Fund Advisors (1.18M shares), RA CAPITAL MANAGEMENT, LLC (1M shares), BlackRock Institutional Trust Company, N.A. (969K shares), COLUMBUS CIRCLE INVESTORS (777K shares), STATE STREET CORP (679K shares), and EVENTIDE ASSET MANAGEMENT, LLC (538K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.